Detroit-based Karmanos Cancer Institute, a network of 16 treatment locations across Michigan and Ohio that is part of McLaren Health Care, is using artificial intelligence to elevate risk assessment and is surfacing high-risk breast…
Continue Reading
Following a record 95 applications, our judges have chosen 25 digital health start-ups to advance to the next stage of Pitchfest 2024 competition. Some of the best start-ups from the UK, Europe, US and even as…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
What You Should Know:
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer…
Continue Reading
Paige redefines cancer detection with a groundbreaking AI derived from the Virchow Pathology Foundation Model. This innovation spans over 17 tissue types, including rare tumors and metastatic deposits. By leveraging a vast repository of…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
The Department of Health and Social Care (DHSC) has said it will take forward a UK National Screening Committee recommendation to increase the use of digital pathology to examine body tissue samples. The use…
Continue Reading
